Douglas Pharmaceuticals - Just another WordPress site

Douglas People & Culture team win HR Team of the Year

Douglas Pharmaceuticals secures US licensing deal to treat high grade cervical dysplasia

Formation of Clinical Advisory Board for Lead Program R-107

Clinicians China licenced to HTDK Pharmaceuticals

New Zealand’s largest medical R&D facility opens in West Auckland

Trial data suggests major breakthrough in Treatment Resistant Depression

Douglas works with 75 year old inventor to create easy to us spray pump for those with arthritis

Douglas wins Best Large Business in the New Zealand International Business Awards

Douglas Pharmaceutical’s Chief Scientific Officer talks about a new drug for treatment resistant depression

Douglas Pharmaceuticals begins work on $35MM Research and Development building